Search

everythinglearnresearchcommunity

for

Search:↓

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Stem cell serum effectively treated hair loss caused by COVID-19.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

People with alopecia areata often have thyroid autoimmunity.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

Early treatment can reverse hair loss from dermal fillers.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

The supplement helps improve hair growth and reduce hair shedding.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Prediabetes may be a risk factor for hair loss.

Hair transplants can risk reactivating lichen planopilaris, a scarring hair loss condition.

Oral minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Dandruff is mainly caused by a scalp reaction to yeast, can worsen hair loss, and antifungal treatments may help.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.